TitleCamrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial
AuthorsWang, Jie
Fan, Yun
Zhao, Jun
Wang, Qiming
Huang, Dingzhi
Li, Xingya
Chen, Jianhua
Fang, Yong
Wang, Zhijie
Zhou, Caicun
Hu, Yanping
Yang, Haihua
Hu, Yi
Zhou, Jianying
Lin, Xiaoyan
Wang, Lifeng
Xu, Yanjun
Li, Hanying
AffiliationChinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
Zhejiang Canc Hosp, Hangzhou, Peoples R China
Beijing Canc Hosp, Beijing, Peoples R China
Henan Canc Hosp, Zhengzhou, Peoples R China
Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
Hunan Canc Hosp, Changsha, Peoples R China
Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China
Tongji Univ, Shanghai Pulm Hosp, Shanghai, Peoples R China
Hubei Canc Hosp, Wuhan, Peoples R China
Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China
Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China
Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China
Nanjing Univ, Med Sch, Drum Tower Hosp, Nanjing, Peoples R China
Jiangsu Hengrui Med Co Ltd, Shanghai, Peoples R China
Issue DateAug-2020
PublisherCANCER RESEARCH
URIhttp://hdl.handle.net/20.500.11897/621742
ISSN0008-5472
DOI10.1158/1538-7445.AM2020-CT083
IndexedSCI(E)
CPCI-S(ISTP)
Appears in Collections:待认领

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.